SCHEMBL20764581

SCHEMBL20764581

N#Cc1ccc(NCc2ccc(C(=O)O)cc2)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ VNN1 O95497 3/20 0.50
▸ SAE1 Q9UBE0 1/20 0.50
▸ UBA2 Q9UBT2 1/20 0.50
▸ CA1 P00915 3/20 0.49
▸ CA2 P00918 3/20 0.49
▸ CA12 O43570 1/20 0.49
▸ CA7 P43166 1/20 0.49
▸ EPHX2 P34913 1/20 0.49
▸ TAS2R14 Q9NYV8 1/20 0.48
▸ ALDH1A1 P00352 1/20 0.48
▸ POLB P06746 1/20 0.48
▸ HPGD P15428 1/20 0.48
▸ HSD17B10 Q99714 1/20 0.48
▸ CTDSP1 Q9GZU7 1/20 0.48
▸ L3MBTL1 Q9Y468 1/20 0.48
▸ LOXL2 Q9Y4K0 1/20 0.47
▸ HDAC6 Q9UBN7 1/20 0.47
▸ CNR1 P21554 1/20 0.47
▸ CNR2 P34972 1/20 0.47
▸ CTNNB1 P35222 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4418236 0.87 CA1 (0.59) CA1CA2ALDH1A1POLBHPGD
SCHEMBL10078294 0.85 LOXL2 (0.63) SAE1UBA2CA1CA2CA12
SCHEMBL5992317 0.85 LOXL2 (0.63) SAE1UBA2CA1CA2CA12
SCHEMBL15376997 0.84 CA1 (0.69) VNN1CA1CA2CA12CA7
SCHEMBL9396971 0.82 FFAR1 (0.60) VNN1
SCHEMBL20764583 0.81 EPHX2 (0.72) EPHX2HDAC6HDAC1KMT2ANAMPT
SCHEMBL6799273 0.80 GAA (0.61) SAE1UBA2CA1CA2CA12
SCHEMBL11246349 0.80 CA1 (0.69) CA1CA2CA12CA7ALDH1A1
SCHEMBL17296519 0.80 CA1 (0.58) CA1CA2ALDH1A1HPGDL3MBTL1
SCHEMBL1446643 0.80 CA1 (0.70) CA1CA2CA12ALDH1A1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3672937-A1 NOVEL CYSTOBACTAMIDE DERIVATIVES Helmholtz-Zentrum für Infektionsforschung GmbH (DE) 2020-07-01 — — EP disclosed
WO-2019038405-A1 NOVEL CYSTOBACTAMIDE DERIVATIVES Helmholtz-Zentrum für Infektionsforschung GmbH (DE) 2019-02-28 — — WO disclosed
Send feedback